Secondary Logo

Institutional members access full text with Ovid®

Share this article on:

Rebuttal Letter to the Editor Kloosterboer et al., Ther Drug Monit 2018;40

344–350

Kloosterboer, Sanne M., MD*,†; de Winter, Brenda C. M., PharmD, PhD*; Bahmany, Soma, BSc*; Al-Hassany, Linda, BSc*; Dekker, Annet, MD; Dieleman, Gwen C., MD; van Gelder, Teun, MD, PhD*; Dierckx, Bram, MD, PhD; Koch, Birgit C. P., PharmD, PhD*

Therapeutic Drug Monitoring: December 2018 - Volume 40 - Issue 6 - p 762
doi: 10.1097/FTD.0000000000000560
Letters to the Editor

Departments of *Hospital Pharmacy and

Child and Adolescent Psychiatry/Psychology, Erasmus MC, Rotterdam, the Netherlands

Middin, The Hague, the Netherlands

The author declares no conflict of interest.

Copyright © 2018 Wolters Kluwer Health, Inc. All rights reserved.